Humanitarian aid needs more focus on tackling gender based violence, urges UNFPA director on 02/04/24
Humanitarian aid programmes need to be even more focused on efforts to combat the rise in sexual and gender based violence (GBV) in countries affected by crises, Natalia Kanem, executive director of the United Nations Population Fund (UNFPA), told Euractiv. What lies ahead for new nicotine products? [Advocacy Lab Content] on 02/04/24
March was a tough month for the vaping sector. An avalanche of political decisions cascaded through public discourse against the background of the European Commission’s evaluation of the EU framework for tobacco control. So, what lies ahead for nicotine products? PFAS bill takes first step in French Parliament on 28/03/24
The French National Assembly's committee of Sustainable Development and country planning unanimously adopted a bill to combat the so-called forever chemicals, or PFAs, on Wednesday (27 March). Europe’s human-animal bond, a special report on EU companion animals [Advocacy Lab Content] on 27/03/24
A Human-Animal Bond Report was launched at the EU Companion Animals Stakeholder Summit on 20 March in Brussels, advocating advancements in companion animal policy to improve human and animal health and wellbeing. Yes, to pet-friendly EU policies, but do we need a commissioner for animals? asks Kaljurand [Advocacy Lab Content] on 27/03/24
MEP Marina Kaljurand (S&D) has questioned whether the European Commission should include a commissioner dedicated to animals, despite the proven benefits of pet ownership. Vandenbroucke takes another jab at slow EU action on tobacco, alcohol on 27/03/24
“Prevention is very much about consumption. Consumption is about what is on the market. When you say market you say EU,” Belgian Health Minister Frank Vandenbroucke told an even in Brussels on Tuesday. Sweden makes naloxone spray an OTC product, to prevent opioid overdose deaths [Advocacy Lab Content] on 26/03/24
Naloxone nasal spray, which can save opioid users from overdoses, will soon be available without prescription in Sweden. The move seeks to increase early interventions outside healthcare settings, marking a major shift in Swedish drug policy. Poland’s vaccine refusals double in five years, alarming officials [Advocacy Lab Content] on 26/03/24
In recent years Poland has witnessed a disturbing surge in the rejection of mandatory immunisations, with the vaccine refusal rate doubling in five years, and thirteen-fold in a decade. De Croo wants EU biotech leadership ambition, cites Belgium’s health and biotech valley [Advocacy Lab Content] on 26/03/24
Europe must work to protect its biotech leadership capability, Belgian Prime Minister Alexander De Croo told Euractiv, aligning Belgium's biotech vision with the European Commission's global ambition. Germany legalises cannabis federally but local opposition anticipated on 22/03/24
After numerous delays, the planned legalisation of cannabis consumption in Germany has passed its last major obstacle - the Bundesrat (Federal Council) and while future growers remain relaxed, they do anticipate further resistance on the local level.
|
|
